Microbix Discloses New Products, Sales, And Capacity
By Microbix Admin | October 29, 2020
Microbix Creates Further COVID-19 Quality Assessment Products
By Microbix Admin | October 20, 2020
Ontario Helps Microbix Ensure Provincial COVID Testing Capacity
By Microbix Admin | October 13, 2020
Microbix Presenting COVID-19 Product Results To Industry
By Microbix Admin | September 22, 2020
Microbix Announces Extension Of Warrant Expiry Dates
By Microbix Admin | September 17, 2020
Microbix Announces Board Changes
By Microbix Admin | September 15, 2020
Microbix’s REDx™ Controls Attain Australian TGA Registration
By Microbix Admin | September 10, 2020
Q3 Fiscal 2020
By Microbix Admin | August 14, 2020
Curious To See How We Perform A COVID Test?
By Microbix Admin | July 21, 2020
Microbix Shares Become Available For U.S. Investors
By Microbix Admin | July 14, 2020
Microbix COVID-19 QAPs Attain EU “CE Mark” Registration
By Microbix Admin | June 5, 2020
Microbix Announces Quality Products Distribution Agreement
By Microbix Admin | June 4, 2020
Microbix Engaged To Develop & Supply Custom QAPs™
By Microbix Admin | June 2, 2020
Microbix Expanding QAPs™ Production Capacity
By Microbix Admin | May 27, 2020
Microbix Achieves Full Utilization Of Its Bioreactors
By Microbix Admin | May 19, 2020
Microbix Announces Quality Products Distribution Agreement
By Microbix Admin | May 15, 2020
Microbix Reports Record Second Quarter Sales
By Microbix Admin | May 14, 2020
Microbix Reports Results For Q2 Fiscal 2020
By Microbix Admin | May 14, 2020
Microbix Announces Quality Products Distribution Agreement
By Microbix Admin | May 12, 2020
Microbix COVID-19 QAPs Now Available for U.S. Labs
By Microbix Admin | May 7, 2020
Microbix COVID-19 QAPs™ Now Available For U.S. Labs
By Microbix Admin | May 7, 2020
Microbix Begins Providing COVID-19 Test Quality Products
By Microbix Admin | May 6, 2020
Microbix Announces Quality Products Distribution Agreement
By Microbix Admin | April 27, 2020
Microbix Participating In COVID-19 Virtual Conference
By Microbix Admin | April 21, 2020
Microbix Attains Health Canada Establishment Licensing
By Microbix Admin | April 21, 2020
How Microbix Core Competency Leads To COVID-19 Products
By Microbix Admin | April 14, 2020
Microbix & Oneworld Create COVID-19 Test Quality Program
By Microbix Admin | April 9, 2020
Microbix Announces Annual And Special Meeting Voting Results
By Microbix Admin | April 1, 2020
Microbix Creates Quality Assessment Product For COVID-19 Tests
By Microbix Admin | March 30, 2020
Microbix Annual General Meeting Process Update
By Microbix Admin | March 25, 2020
Microbix Announces Quality Products Distribution Agreement
By Microbix Admin | March 24, 2020
Microbix Announces Issuance Of Stock Options
By Microbix Admin | February 25, 2020
Microbix Reports Results For Q1 Fiscal 2020
By Microbix Admin | February 13, 2020
Microbix Completes Non-Brokered Private Placement Of $2.3 Million
By Microbix Admin | January 31, 2020
Microbix Reports Results For Fiscal 2019
By Microbix Admin | December 20, 2019
Microbix Invited To Present Product Results At HPV Congress
By Microbix Admin | December 2, 2019
Microbix Wins Ontario Business Award
By Microbix Admin | November 18, 2019
Microbix Presenting Product Results At Industry Conference
By Microbix Admin | October 8, 2019
Microbix Presenting At StableView TECH19 Conference
By Microbix Admin | October 1, 2019
Microbix Presenting At Muskoka Capital Conference
By Microbix Admin | September 25, 2019
Microbix Quality Products Enter U.S. Market
By Microbix Admin | September 19, 2019
Microbix Quality Products Attain European Registration
By Microbix Admin | September 5, 2019
Microbix Reports Results For Q3 Fiscal 2019
By Microbix Admin | August 12, 2019
Microbix Provides Bioreactor Update
By Microbix Admin | August 1, 2019
FedDev Ontario Supports New Microbix Facility In Mississauga
By Microbix Admin | July 30, 2019
Microbix Reports Results For Q2 Fiscal 2019
By Microbix Admin | May 13, 2019
Microbix To Present At Bloom Burton Conference
By Microbix Admin | April 29, 2019
Microbix Announces Management Changes
By Microbix Admin | April 18, 2019
Microbix Announces Annual Meeting Voting Results
By Microbix Admin | March 28, 2019
Microbix Announces Issuance Of Stock Options
By Microbix Admin | February 25, 2019
Microbix Reports Results For Q1 Fiscal 2019
By Microbix Admin | February 12, 2019
Microbix Provides Quality Assessment Products Update
By Microbix Admin | February 5, 2019
Microbix Enhances Quality Management System
By Microbix Admin | December 24, 2018
Microbix Reports Results For Fiscal 2018
By Microbix Admin | December 21, 2018
Microbix Wins Business Award Of Excellence
By Microbix Admin | November 19, 2018
Microbix Exhibiting At MEDICA Trade Fair
By Microbix Admin | November 6, 2018
Microbix To Present At Muskoka Capital Conference
By Microbix Admin | September 27, 2018
Microbix Reports Record Third Quarter Sales
By Microbix Admin | August 14, 2018
Microbix Exhibiting At AACC Exposition
By Microbix Admin | July 26, 2018
Microbix To Present At Okanagan Capital Conference
By Microbix Admin | July 12, 2018
Microbix Reports Record Second Quarter Sales
By Microbix Admin | May 14, 2018
Microbix Completes Multiple Facility Upgrades
By Microbix Admin | May 8, 2018
Microbix To Present At Bloom Burton Conference
By Microbix Admin | April 30, 2018
Microbix Engages Drug Licensing Advisor
By Microbix Admin | April 26, 2018
Microbix Announces Annual And Special Meeting Voting Results
By Microbix Admin | April 3, 2018
Microbix Reports Record First Quarter Sales – Year-Over-Year Sales Growth Of 48%
By Microbix Admin | February 14, 2018
Microbix Featured At Cantech Investment Conference
By Microbix Admin | January 29, 2018
Microbix Expands Quality Assessment Product Family
By Microbix Admin | January 18, 2018
Microbix Reports Full Year And Fourth Quarter Results – Record Sales Of $10.2 Million Achieved For Fiscal 2017
By Microbix Admin | December 21, 2017
Microbix Confirms Ramp-Up Of Production – Bioreactor Capacity Increasing By 500%
By Microbix Admin | November 27, 2017
Microbix Completes Second Tranche Of Brokered Private Placement Tranche Gross Proceeds Of $1,164,640, Total Proceeds Of $3,500,000
By Microbix Admin | October 27, 2017
Microbix Completes Brokered Private Placement – Gross Proceeds Of $2.3 Million
By Microbix Admin | October 19, 2017
Microbix Announces End Of Legal Dispute – Allegations By ZeptoMetrix Withdrawn
By Microbix Admin | October 11, 2017
Microbix Announces First Shipment Of Bioreactor Antigen
By Microbix Admin | September 13, 2017
Microbix To Amend Share Purchase Warrant Terms
By Microbix Admin | August 24, 2017
Microbix Reports Record Third Quarter & Nine Month Sales – Year-Over-Year Sales Growth Exceeding 20%
By Microbix Admin | August 14, 2017
